Medicine ingestion state management method, medicine and medicine ingestion state management device

• US 10,265,139 B2
• Filed: 01/26/2016
• Issued: 04/23/2019
• Est. Priority Date: 09/02/2003
• Status: Active Grant

• Current Assignee: Fujitsu Limited
• Original Assignee: Fujitsu Limited
• Inventors: Kimura, Hitoshi, Notani, Morihito
• Primary Examiner(s): Morgan, Robert W
• Assistant Examiner(s): Coleman, Charles P
• Application Number:
  US15/006,291
• Publication Number:
  US 20160135919A1
• Time in Patent Office: 1,183 Days
• Field of Search: 705 2, 705 3, 705 20
• CPC Class Codes: A61B 5/073 Intestinal transmitters
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61B 90/98 using electromagnetic means, e.g. transponders
• CPC Class Codes: A61J 3/007 Marking tablets or the like apparatus for printing on tablets or the like B41F17/36
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/13 delivered from dispensers

Abstract

Disclosed is a medicine ingestion state management method capable of objectively managing medicine ingestion states of patients. The medicine ingestion state management method involves an operation of prescribing medicine (10) encapsulating, together with a medicament, a medicine information transmitting unit (20) having a function of transmitting medicine information capable of specifying a type and a quantity of the medicament to each individual patient, and an operation of grasping the medicine ingestion state of each patient by collecting the medicine information from each medicine information transmitting unit (20) in each patient.

Claims

1. A swallowable medicament, comprising:

a combination of a medicine and an IC chip, the combination being made using a material soluble by gastric juice,

wherein the IC chip includes an electrode and starts a given operation using power generated by exposure of the electrode to the gastric juice,

wherein the exposure of the electrode to the gastric juice is caused by dissolution of the material by the gastric juice.

2. The swallowable medicament according to claim 1, wherein the IC chip includes a memory, and the given operation includes an access to the memory.

3. A medicament, comprising:

a medicine; and

an IC chip exists in the medicament in a status mixed with the medicine,

wherein the IC chip has an electrode that forms a battery by contact with gastric juice and the IC chip operates in response to power supply from the battery,

wherein the contact between the electrode and the gastric juice is caused by dissolution of a material soluble by the gastric juice covering the electrode.

4. A medicament, comprising:

an IC chip that has an electrode to form a battery within a body and starts a given operation using power generated by exposure of the electrode to gastric juice; and

a medicine that exists on a contact position with the electrode of the IC chip and is dissolved within the body,

wherein the exposure of the electrode to the gastric juice is caused by dissolution of the material by the gastric juice.